Allotment Of 1,30,90,200 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 7,25,00,000 Fully Convertible Equity Warrants (''''Warrants'''')
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Mardia Samyoung Capillary Tubes Company Ltd allotted 1,30,90,200 fully convertible equity warrants to promoter Torextron Ventures Private Limited on February 5, 2026, at an issue price of Rs. 13.50 per warrant (including a premium of Rs. 3.50 over the Rs. 10 face value). This is the second tranche of a preferential allotment approved by shareholders at the EGM held on October 29, 2025, and cleared by BSE on January 23, 2026. Torextron Ventures already held 23.51% of the company pre-issue; assuming full conversion, its stake will move to 21.99% of the expanded capital. The company has collected 25% of the consideration upfront, with the remaining 75% payable at the time of conversion, which must happen within 18 months. There is no change in the paid-up share capital right now since only warrants (not shares) have been issued.
Existing public shareholders face potential dilution once the warrants are converted into equity shares over the next 18 months. The promoter increasing its stake signals confidence in the company, but the actual equity inflow to the company happens only when warrants are exercised.